How long has xgeva been on the market?

How long has Xgeva (denosumab) been on the market?

Xgeva has been on the market since 2010. The U.S. approval (FDA) for Xgeva occurred in June 2010, which is the typical reference point for “on the market” timing in the U.S. 1.

When did Xgeva first get approved (and what does that mean for “on the market”)?

For most searches about “how long” a drug has been available, the key date is the first regulatory approval. Xgeva’s FDA approval in 2010 means it became commercially available following that authorization in the U.S. 1.

Are there different dates for other countries or indications?

“On the market” can differ by country because approvals happen at different times and may also expand to new indications later. If you mean a specific country (e.g., EU, UK, Canada) or a specific indication (like prevention of skeletal-related events in cancer vs. treatment of giant cell tumor of bone), tell me and I can anchor the timeline to that approval date.

Source